Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 15, Number 10—October 2009

Research

A Model-based Assessment of Oseltamivir Prophylaxis Strategies to Prevent Influenza in Nursing Homes

Carline van den DoolComments to Author , Eelko Hak, Marc J.M. Bonten1, and Jacco Wallinga1
Author affiliations: University Medical Center, Utrecht, the Netherlands (C. van den Dool, E. Hak, M.J.M. Bonten, J. Wallinga); University Medical Center, Groningen, the Netherlands (E. Hak); National Institute for Public Health and the Environment, Bilthoven, the Netherlands (J. Wallinga)

Main Article

Figure 4

The number of daily doses of oseltamivir needed to prevent 1 influenza virus infection or disease (DNP). Results are shown for both postexposure (PE) prophylaxis and continuous (cont) prophylaxis for increasing proportions of oseltamivir-resistant virus strains in the community.

Figure 4. The number of daily doses of oseltamivir needed to prevent 1 influenza virus infection or disease (DNP). Results are shown for both postexposure (PE) prophylaxis and continuous (cont) prophylaxis for increasing proportions of oseltamivir-resistant virus strains in the community.

Main Article

1These authors contributed equally to this article.

Top of Page

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO